A Phase I/II clinical study to evaluate the pharmacokinetics, pharmacodynamics, and safety of AKP-022 in healthy premenopausal Japanese adult female subjects.
Latest Information Update: 27 Jun 2024
At a glance
- Drugs Estradiol/norethisterone acetate/relugolix (Primary)
- Indications Pain; Pregnancy; Uterine leiomyoma
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
Most Recent Events
- 27 Jun 2024 New trial record